Jazz Pharmaceuticals
JAZZ
#2292
Rank
S$8.22 B
Marketcap
$135.47
Share price
3.03%
Change (1 day)
-8.60%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.91

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.85. In 2022 the company made an earnings per share (EPS) of -$4.64 an increase over its 2021 EPS that were of -$7.05.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.91-58.9%
2022-$4.64-34.2%
2021-$7.05-224.83%
2020$5.65-53.25%
2019$12.0823.59%
2018$9.78-8.24%
2017$10.6523.74%
2016$8.6122.12%
2015$7.05478.49%
2014$1.22-74.93%
2013$4.86-27.11%
2012$6.6769.1%
2011$3.94245.98%
2010$1.14-462.5%
2009-$0.31-96.7%
2008-$9.54-27.04%
2007-$13.0865.47%
2006-$7.90-4.59%
2005-$8.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.27 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.86-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.90-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.62 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel